Alkermes to Present at the Cantor Fitzgerald Global Healthcare Conference

DUBLIN, Sept. 26, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on Thursday, Oct. 3, 2019 at 7:45 a.m. ET (12:45 p.m. BST) from New York. The audio portion of the fireside chat may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases and oncology. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction, multiple sclerosis and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:Alex BraunInvestor Relations+1 781 296 8493

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-300926395.html

SOURCE Alkermes plc